Novavax Found 96% Effective Against COVID
New York: US-based biotech company Novavax’s Covid-19 vaccine was 96.4 per cent effective against original strain of the virus in a phase-3 trial in the UK, the company has said.
The vaccine, NVX-CoV2373, was found 86.3 per cent!-->!-->!-->…
Read More...
Read More...